Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last kr4.84 SEK
Change Today +0.01 / 0.21%
Volume 14.2K
KAN On Other Exchanges
As of 3:32 AM 11/30/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Karolinska Institutet Science Park

Banvaktsvägen 22

Solna, 171 48


Phone: 46 8 50 12 60 80


Kancera AB, a biotechnology company, engages in the development and sale of drug candidates that cure or stop the progression of cancer. The company develops drugs for the treatment of leukemia and solid tumors, based on blocking survival signals in the cancer cell and on addressing cancer metabolism. Its pharmaceutical development projects include ROR inhibitors, which are drug candidate for treatment of leukemia and solid tumors; and PFKFB inhibitors for reducing cancer’s energy supply, as well as epigenetic pharmaceutical development targeting cancer and parasitic diseases. The company was founded in 2010 and is based in Solna, Sweden.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KAN:SS kr4.84 SEK +0.01

KAN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KAN.
View Industry Companies

Industry Analysis


Industry Average

Valuation KAN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1,663.5x
Price/Book 17.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1,449.1x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KANCERA AB, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at